This brand name is authorized in Nigeria.
The drug XOLSTAT contains one active pharmaceutical ingredient (API):
1
|
UNII
83MVU38M7Q - ROSUVASTATIN CALCIUM
|
|
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-6098 | Tablet | Xolstat Tablets 10mg TAB 10 mg 2 X 7packs | 86 RNW-PP-158506 Xolstat Tablets 10mg ROSUVASTATIN CALCIUM TABLETS 10MG Rosuvastatin Calcium eq. to Rosuvastatin 10mg, Microcrystalline Cellulose, Lactose Monohydrate, Crospovidone, Magnesium Stearate, Sodium Citrate, Opadry Pink, Purified Water B4-6098 Drugs CARDIOVASCULAR SYSTEM Imported Products 27packs Prescription Only Medicine (POM) 9/3/2020 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO LAGOS LAGOS 17932744 rosanna.iwuala@sunpharma.com SUN PHARMACEUTICAL LTD (INDIA), Village Ganguwala, Paonta Sahib, Himachal Pradesh – 173025, India , India | 28/03/2023 |
| B4-6099 | Tablet | Xolstat Tablets 20mg TAB 20 mg 27packs | Xolstat Tablets 20mg ROSUVASTATIN CALCIUM TABLETS 20MG Rosuvastatin Calcium eq. to Rosuvastatin 20mg, Microcrystalline Cellulose, Lactose Monohydrate, Crospovidone, Magnesium Stearate, Sodium Citrate, Opadry Pink, Purified Water B4-6099 Drugs Imported Products 27packs Prescription Only Medicine (POM) 03/09/2020 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO LAGOS LAGOS 17932744 rosanna.iwuala@sunpharma.com SUN PHARMACEUTICAL LTD (INDIA), Village Ganguwala, Paonta Sahib, Himachal Pradesh – 173025, India , India | 26/04/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C10AA07 | Rosuvastatin | C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-6098, B4-6099 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.